FOR YOUR PATIENTS

Explaining Percepta GSC test to patients

In the event a bronchoscopy doesn’t show a conclusive result, you can order the Percepta Genomic Sequencing Classifier (GSC) test. Percepta GSC uses RNA whole-transcriptome sequencing with machine learning, to stratify the risk of primary lung cancer to guide patient management.

Help your qualified patients

At the start of the bronchoscopy procedure, collect samples from the airway using a small brush and send samples to Veracyte.

Logo of lungs undergoing a bronchoscopy. A lesion is visible.

Smoking can cause lasting changes to the genes inside the cells in your airway.

The Percepta GSC test looks for and analyzes these genomic changes.

The Percepta GSC results stratify the risk of primary lung cancer to guide patient management.

Photo of the patient handout

Patient handout

This handout may help healthcare professionals discuss the Percepta Genomic Sequencing Classifier with patients and how the test works.

Billing and reimbursement

Client services:
1.844.464.5864

Customer support:
support@veracyte.com

Covered by Medicare

The Percepta GSC  test is covered by Medicare. Veracyte bills Medicare and third-party payers directly. 

 

The Veracyte Access Program provides financial support for both eligible uninsured and commercially available insured patients with financial need.